These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3828945)

  • 1. Circulating IgA immune complexes in head and neck cancer, nasopharyngeal carcinoma, lung cancer, and colon cancer.
    Baseler MW; Maxim PE; Veltri RW
    Cancer; 1987 May; 59(10):1727-31. PubMed ID: 3828945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composition of IgA immune complexes precipitated with polyethylene glycol. A model for isolation and analysis of immune complexes.
    Imai H; Chen A; Wyatt RJ; Rifai A
    J Immunol Methods; 1987 Nov; 103(2):239-45. PubMed ID: 3668260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulating immune complexes in malignant tumors].
    Savina NP
    Sov Med; 1989; (8):8-10. PubMed ID: 2814673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The specific detection of IgA in immune complexes.
    Kauffmann RH; Van Es LA; Daha MR
    J Immunol Methods; 1981; 40(2):117-29. PubMed ID: 7019333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.
    Hutajulu SH; Fachiroh J; Argy G; Indrasari SR; Indrawati LPL; Paramita DK; Jati TBR; Middeldorp JM
    PLoS One; 2017; 12(8):e0180683. PubMed ID: 28800616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in patients with nasopharyngeal carcinoma.
    Wolf GT; Wolfe RA
    Laryngoscope; 1990 Mar; 100(3):302-8. PubMed ID: 1689798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
    Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M
    Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.
    Xia C; Zhu K; Zheng G
    Int J Clin Exp Pathol; 2015; 8(12):16104-10. PubMed ID: 26884888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
    Chen H; Chi P; Wang W; Li L; Luo Y; Fu J; Zhang L; Liu W
    Int J Infect Dis; 2014 Aug; 25():110-5. PubMed ID: 24878579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes.
    Fuchs C; Krapf F; Kern P; Hoferichter S; Jäger W; Kalden JR
    Cancer Immunol Immunother; 1988; 26(2):180-4. PubMed ID: 3282655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma.
    Puthavathana P; Kositanont U; Chongkolwatana C; Metheetrairut C; Chantarakul N; Nuntarakchaikul S; Wasi C
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):39-43. PubMed ID: 8216557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
    Gunvén P; Klein G; Henle W; Henle G; Forsby N
    Biomed Pharmacother; 1983; 37(1):41-4. PubMed ID: 6311307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of IgA against Epstein-Barr virus BZLF-1 replication activator (ZEBRA) in sera of nasopharyngeal carcinoma patients with a recombinant ZEBRA protein.
    Shu CH; Tu TY; Lin LS; Ro LH; Lo MS; Huang CH; Chen KY; Liu WT
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):350-5. PubMed ID: 10389292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Epstein-Barr virus immunoglobulin G-based approach for the specific detection of nasopharyngeal carcinoma.
    Abdulamir AS; Hafidh RR; Abu Bakar F; Abbas K
    Am J Otolaryngol; 2010; 31(6):410-7. PubMed ID: 20015794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.
    Xu XF; Lu RQ; Xiao R; Zhou L; Zhao XM; Hu XC; Gao X; Guo L
    Cancer Biomark; 2016; 16(3):467-76. PubMed ID: 27062704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes in IgA nephropathy: presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes.
    Sancho J; Egido J; Rivera F; Hernando L
    Clin Exp Immunol; 1983 Oct; 54(1):194-202. PubMed ID: 6616968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble immune complexes and squamous cell carcinoma-related antigens in patients with head and neck cancer.
    Yamanaka N; Himi T; Harabuchi Y; Hoki K; Kataura A
    Cancer; 1988 Nov; 62(9):1932-8. PubMed ID: 3167806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental histoplasmosis in the mouse. Immunoglobulin class response, total immunoglobulin A levels, immune complex formation, and occurrence of antigen in serum and urine.
    Sweet GH; Dulohery SM
    Am Rev Respir Dis; 1989 Oct; 140(4):967-73. PubMed ID: 2508525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.